Project Grant 80NSSC22K0803

This federal Project Grant award of $170,678 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research to develop continuous electrochemical sensors for in-vivo monitoring of large analytes like proteins and peptides. The goal is to create sensors with unprecedented sensitivity (>1000% change in response) to enable continuous monitoring of...

The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $450,000 Project Grant to the Texas A&M Engineering Experiment Station (Tees) to develop an injectable, grain-of-rice size glucose biosensor for continuous blood sugar monitoring. The key products or services to be provided under this 3-year grant include: Developing an injectable glucose biosensor comprised of a self-cleaning membrane and a near-infrared fluorescence...

This $260,467 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) aims to develop ultrasensitive ion-selective optodes to measure blood electrolytes, including calcium, sodium, potassium, magnesium, and chloride ions. The research project at Virginia Commonwealth University (VCU) focuses on creating a handheld electrolyte...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the federal Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop living biosensors for detecting and analyzing DNA at the single-base level without requiring sample purification or specialized equipment. The $257,807 award to the University of California, San Diego will demonstrate the use of these biosensors to rapidly...

This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $511,798 was awarded to Kilele Health Inc. on June 15, 2022 to develop continuous diagnostic monitoring platforms beyond glucose sensing. Unlike existing enzymatic glucose sensors, the company will utilize electrochemical aptamer sensors that can rapidly measure other molecules in the body with high specificity and sensitivity. The aim is to address limitations that have...

Infusense Corporation was awarded a $253,590 Project Grant from the National Science Foundation on August 15, 2021 to develop a point-of-care electrochemical platform for the rapid detection of drug toxicity. The project is being conducted under the NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and innovation. Specifically, Infusense will leverage the one-year funding period ending July 31, 2022 to create a...

This $450,000 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) to The Johns Hopkins University supports the development of a new "dual-series gate" organic electrochemical transistor (DS-OECT) biosensor technology. The key objectives include material synthesis, device fabrication, computer modeling, and biological fluid analysis to create a highly sensitive and stable sensor capable of reliably detecting protein biomarkers for various...

This National Science Foundation (NSF) Integrative Activities (CFDA 47.083) project grant award of $299,712 to the University of South Carolina aims to develop and characterize electrochemical aptamer-based (E-AB) sensors for rapid, sensitive, and multi-analyte detection of cardiovascular disease (CVD) biomarkers. The project will integrate carbon-based electrode arrays with nano-sized designs and advanced aptamer technology to enhance the stability and performance of the E-AB sensors. The...

This National Science Foundation (NSF) Biological Sciences grant award provides $2,225,964 to the Georgia Tech Research Corporation (Georgia Tech) to develop a novel biosensing platform called "protocell communities" that can be used for rapid, low-cost medical diagnostics. The project aims to create a tool that can diagnose medical conditions by detecting and integrating multiple indicator molecules, addressing limitations of single-analyte diagnostics. The protocell technology uses...

The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...